Results 151 to 160 of about 6,803 (205)

Bilateral Macular Holes with Depleted Internal Limiting Membrane in Alport Syndrome Patient: A Case Report. [PDF]

Korean J Ophthalmol
Suh YK, Bae K, Park UC.
europepmc   +1 more source

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome. [PDF]

Pediatr Nephrol
Lo Re C, Kim JJ, Fornoni A.
europepmc   +1 more source

Systematic metabolomic study on the plasma and urine of a mouse model of Alport syndrome. [PDF]

Sci Rep
Choi HS, Oh S, Ji M, Choi B, Suh SH, Kim CS, Ma SK, Kim SW, Paik MJ, Bae EH.   +9 more
europepmc   +1 more source

Modulation of the Apolipoprotein M/S1PR4 Pathway Reduces Podocyte Lipid Overload in Alport Syndrome via Distinct Autophagy and Efflux Mechanisms. [PDF]

J Am Soc Nephrol
Tolerico M, Molina J, Insenga A, Carrazco A, Njeim R, Sloan A, Griswold A, Kurano M, Mendez A, Nathans R, Bolek R, Ettou S, Berasi S, Fornoni A, Merscher S.   +14 more
europepmc   +1 more source

Splice modulation of COL4A5 reinstates collagen IV assembly in an organoid model of Alport syndrome. [PDF]

JCI Insight
Saei H, Estebe B, Goudin N, Esmailpour M, Haure J, Gribouval O, Arrondel C, Moriniere V, Tian P, Lennon R, Antignac C, Mollet G, Dorval G.   +12 more
europepmc   +1 more source

Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome. [PDF]

Am J Physiol Renal Physiol
Miyata KN, Smith DM, Yamashita M, Kim S, Yeargin FA, Beganovic M, Zhang SL, Chan JSD, Miner JH, Leal DN, Li JP, Bruno J.   +11 more
europepmc   +1 more source

Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model. [PDF]

Life Sci Alliance
Kaseda S, Horizono J, Sannomiya Y, Kuwazuru J, Suico MA, Sato R, Fukiya H, Sunamoto H, Ogi S, Matsushita T, Koyama Y, Owaki A, Tsuhako H, Shiraga M, Watanabe H, Nakano T, Davenport B, Nozu K, Yamamoto M, Shuto T, Tokunaga Y, Lennon R, Onuma K, Kai H.   +23 more
europepmc   +1 more source

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells. [PDF]

Kidney360
Zheng Q, Zhao Y, Jin Y, Yu S, Liu Y, Yu H, Fang Z, Yang L, Weng Q, Xu J, Pan X, Gu X, Xie J.   +12 more
europepmc   +1 more source

A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN. [PDF]

BMC Nephrol
Ozcan SG, Koc E, Murt A, Dincer MT, Gurses I, Seyahi N, Trabulus S.   +6 more
europepmc   +1 more source